FilingSEC EDGAR8-K
InMed Pharmaceuticals Announces Merger Approval and Completion of 1-for-10 Share Consolidation
· SEC accepted
StageMerger approved and share consolidation completed
Filing content
Shareholders approved the merger with Mentari Therapeutics and a corporate name change, while the company completed a 1-for-10 share consolidation effective November 5.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…